XORTX Intangible Assets vs Total Current Liabilities Analysis

XRTX Stock  USD 1.19  0.03  2.59%   
XORTX Therapeutics financial indicator trend analysis is more than just analyzing XORTX Therapeutics current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether XORTX Therapeutics is a good investment. Please check the relationship between XORTX Therapeutics Intangible Assets and its Total Current Liabilities accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

Intangible Assets vs Total Current Liabilities

Intangible Assets vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of XORTX Therapeutics Intangible Assets account and Total Current Liabilities. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between XORTX Therapeutics' Intangible Assets and Total Current Liabilities is -0.34. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of XORTX Therapeutics, assuming nothing else is changed. The correlation between historical values of XORTX Therapeutics' Intangible Assets and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of XORTX Therapeutics are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Intangible Assets i.e., XORTX Therapeutics' Intangible Assets and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

-0.34
Relationship DirectionNegative 
Relationship StrengthInsignificant

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Total Current Liabilities

Total Current Liabilities is an item on XORTX Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of XORTX Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from XORTX Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into XORTX Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.Selling General Administrative is likely to drop to about 996.5 K in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
 2021 2022 2023 2024 (projected)
Reconciled Depreciation17.9K55.5K139.7K146.7K
Research Development669.1K6.5M2.4M1.6M

XORTX Therapeutics fundamental ratios Correlations

-0.070.820.98-0.27-0.99-0.50.530.990.90.990.760.620.340.891.0-0.35-0.43-0.740.910.22-0.620.560.97-0.150.97
-0.070.35-0.13-0.750.140.00.35-0.14-0.14-0.14-0.16-0.08-0.20.14-0.060.0-0.050.21-0.17-0.55-0.410.28-0.120.25-0.09
0.820.350.8-0.51-0.81-0.140.440.810.60.810.350.240.220.770.83-0.09-0.17-0.340.62-0.3-0.50.370.810.190.84
0.98-0.130.8-0.23-0.98-0.490.390.980.880.980.710.610.440.80.98-0.38-0.45-0.750.920.19-0.580.560.93-0.170.99
-0.27-0.75-0.51-0.230.20.41-0.33-0.21-0.31-0.21-0.14-0.35-0.35-0.31-0.260.210.280.25-0.310.190.56-0.52-0.150.19-0.29
-0.990.14-0.81-0.980.20.44-0.51-1.0-0.88-1.0-0.73-0.57-0.32-0.88-0.990.310.380.7-0.89-0.230.54-0.48-0.980.12-0.97
-0.50.0-0.14-0.490.410.44-0.36-0.43-0.72-0.43-0.77-0.98-0.61-0.37-0.470.690.760.87-0.76-0.580.77-0.87-0.310.8-0.48
0.530.350.440.39-0.33-0.51-0.360.510.550.510.670.38-0.330.830.52-0.15-0.23-0.30.330.28-0.570.440.580.110.34
0.99-0.140.810.98-0.21-1.0-0.430.510.881.00.730.570.320.890.99-0.3-0.37-0.70.880.23-0.540.480.98-0.110.97
0.9-0.140.60.88-0.31-0.88-0.720.550.880.880.880.790.460.80.88-0.4-0.48-0.870.920.55-0.630.70.83-0.340.85
0.99-0.140.810.98-0.21-1.0-0.430.511.00.880.730.570.320.890.99-0.3-0.37-0.70.880.23-0.540.480.98-0.110.97
0.76-0.160.350.71-0.14-0.73-0.770.670.730.880.730.820.20.740.74-0.59-0.65-0.780.780.62-0.720.770.7-0.350.65
0.62-0.080.240.61-0.35-0.57-0.980.380.570.790.570.820.620.470.6-0.7-0.77-0.910.850.57-0.780.850.45-0.780.6
0.34-0.20.220.44-0.35-0.32-0.61-0.330.320.460.320.20.62-0.040.32-0.38-0.41-0.630.660.19-0.310.460.14-0.750.5
0.890.140.770.8-0.31-0.88-0.370.830.890.80.890.740.47-0.040.89-0.18-0.27-0.540.680.22-0.580.460.930.080.78
1.0-0.060.830.98-0.26-0.99-0.470.520.990.880.990.740.60.320.89-0.35-0.42-0.710.890.18-0.610.540.97-0.130.97
-0.350.0-0.09-0.380.210.310.69-0.15-0.3-0.4-0.3-0.59-0.7-0.38-0.18-0.350.990.49-0.53-0.170.75-0.77-0.20.53-0.36
-0.43-0.05-0.17-0.450.280.380.76-0.23-0.37-0.48-0.37-0.65-0.77-0.41-0.27-0.420.990.58-0.61-0.20.83-0.84-0.270.56-0.43
-0.740.21-0.34-0.750.250.70.87-0.3-0.7-0.87-0.7-0.78-0.91-0.63-0.54-0.710.490.58-0.91-0.620.61-0.71-0.60.65-0.73
0.91-0.170.620.92-0.31-0.89-0.760.330.880.920.880.780.850.660.680.89-0.53-0.61-0.910.38-0.680.70.79-0.530.92
0.22-0.55-0.30.190.19-0.23-0.580.280.230.550.230.620.570.190.220.18-0.17-0.2-0.620.38-0.070.260.2-0.480.11
-0.62-0.41-0.5-0.580.560.540.77-0.57-0.54-0.63-0.54-0.72-0.78-0.31-0.58-0.610.750.830.61-0.68-0.07-0.94-0.470.39-0.58
0.560.280.370.56-0.52-0.48-0.870.440.480.70.480.770.850.460.460.54-0.77-0.84-0.710.70.26-0.940.38-0.480.54
0.97-0.120.810.93-0.15-0.98-0.310.580.980.830.980.70.450.140.930.97-0.2-0.27-0.60.790.2-0.470.380.040.91
-0.150.250.19-0.170.190.120.80.11-0.11-0.34-0.11-0.35-0.78-0.750.08-0.130.530.560.65-0.53-0.480.39-0.480.04-0.21
0.97-0.090.840.99-0.29-0.97-0.480.340.970.850.970.650.60.50.780.97-0.36-0.43-0.730.920.11-0.580.540.91-0.21
Click cells to compare fundamentals

XORTX Therapeutics Account Relationship Matchups

XORTX Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.1M2.3M17.3M12.3M5.5M5.0M
Other Current Liab641.5K728.4K229.0K151.4K87.6K83.2K
Total Current Liabilities1.3M1.0M4.2M1.5M294.9K280.2K
Total Stockholder Equity(211.7K)1.3M13.1M7.0M4.6M3.1M
Property Plant And Equipment Net731.0341.00.092.5K23.9K28.8K
Net Debt(7.8K)(171.3K)(14.8M)(10.3M)(3.4M)(3.6M)
Retained Earnings(6.8M)(8.0M)(7.6M)(14.1M)(23.7M)(22.5M)
Accounts Payable607.4K305.8K324.0K1.3M195.8K186.0K
Cash58.6K171.3K14.8M10.4M3.4M3.6M
Non Current Assets Total272.7K234.3K1.5M1.5M1.4M731.9K
Cash And Short Term Investments58.6K171.3K14.8M10.4M3.4M3.6M
Net Receivables15.5K14.4K40.7K81.8K60.7K35.1K
Common Stock Shares Outstanding595.5K740.4K1.1M1.5M2.0M2.1M
Liabilities And Stockholders Equity1.1M2.3M17.3M12.3M5.5M5.0M
Other Stockholder Equity683.0K0.05.0M(2.1M)5.8M6.1M
Total Liab1.3M1.0M4.2M5.4M825.9K784.6K
Total Current Assets815.2K2.1M15.8M10.9M4.1M4.2M
Short Long Term Debt Total272.5K43.3K50.8K77.4K11.5K10.9K
Intangible Assets272.4K234.3K201.0K199.4K175.3K189.0K
Net Tangible Assets(484.1K)1.0M16.5M9.2M10.6M11.1M
Net Invested Capital(160.9K)1.3M16.7M7.0M4.6M4.6M
Net Working Capital(484.5K)1.0M14.9M9.4M3.8M4.3M
Other Current Assets741.2K1.9M1.0M379.6K560.4K701.0K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.